Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development - the-scientist.com
#Cytiva collaborate#drug development#accelerate characterization#Nuclera#Cytiva
Life Science News
Latest updates from the biotech and pharma world
Cytiva Subsidiary Seeks to Quash Subpoena Issued in Amgen’s US Denosumab Litigation Against Accord & Intas - Pearce IP
#Subsidiary Seeks#Quash Subpoena#Subpoena Issued#Denosumab Litigation#Cytiva Subsidiary
Nuclera and Danaher-owned US ally boost protein proposition - Business Weekly
#Business Weekly#ally boost#boost protein#Weekly Nuclera#protein proposition
Improving CGT Production to Speed Delivery and Lower Cost - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#CGT Production#Speed Delivery#Lower Cost#Improving CGT
Producer Cell Lines: Large-Scale Gene Therapy Hitmakers - GEN - Genetic Engineering and Biotechnology News
#Cell Lines#Genetic Engineering#Gene Therapy#Large-Scale Gene#Therapy Hitmakers
Xcellerex 500 L and 2,000 L Bioreactors - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Bioreactors GEN#Genetic#GEN#Engineering
Cytiva and Asimov Collaborate on NextGen Cell Line Design and Process Development - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Asimov Collaborate#Cell Line#Line Design#Process Development
Cytiva develops two new protein A resins bringing cost efficiency to mAb capture - BioSpectrum India
#Cytiva develops#BioSpectrum India#resins bringing#bringing cost#cost efficiency
Cytiva expands portfolio with new MabSelect Resins made from renewable agarose for scalable, cost-efficient mAb manufacturing - Express Pharma
#Express Pharma#MabSelect Resins#Resins made#cost-efficient mAb#Cytiva expands
Unlocking the Potential of PROTACs in Drug Discovery - Technology Networks
#Drug Discovery#Technology Networks#Discovery Technology#Networks Unlocking#Potential
Cytiva expands MabSelect resin portfolio with new solutions for cost-effective and scalable mAb purification - BioSpectrum Asia
#Cytiva expands#BioSpectrum Asia#expands MabSelect#MabSelect resin#resin portfolio
Cytiva broadens Xcellerex X-platform to include 500 L and 2000 L bioreactors - SelectScience
#Xcellerex X-platform#broadens Xcellerex#Cytiva broadens#SelectScience Cytiva#bioreactors SelectScience
Cytiva Expands Bioreactor Portfolio with Addition of 500-L and 2000-L Bioreactors, Which Will be Exhibited at INTERPHEX 2025 - BioPharm International
#Expands Bioreactor#Bioreactor Portfolio#Cytiva Expands#BioPharm International#International Cytiva
Trends shaping the Healthcare and Bioscience industries in 2025 - BioSpectrum Asia
#BioSpectrum Asia#Bioscience industries#Trends shaping#Asia Trends#Healthcare
Massachusetts manufacturing facility to lay off 85 employees - NBC Boston
#NBC Boston#Massachusetts manufacturing#manufacturing facility#Boston Massachusetts#employees NBC
Tech and service specialist Cytiva charts 85 layoffs at Massachusetts production site - Fierce Pharma
#Cytiva charts#Fierce Pharma#specialist Cytiva#Massachusetts production#service specialist
Mass. life sciences manufacturing facility to lay off 85 - The Business Journals
#Business Journals#Journals Mass#life sciences#Mass#Business
85 Mass. employees face layoffs from leading biotech company by month’s end - MassLive
#Mass#employees face#face layoffs#leading biotech#biotech company
Cytiva Senior R&D Scientist Downstream- Lifescience Candidates Apply Now! - BioTecNika
#Scientist Downstream#Lifescience Candidates#Candidates Apply#Cytiva Senior#Downstream
Revolutionary approaches to drug design: how AI is transforming life sciences - Pharmaceutical Technology
#Pharmaceutical Technology#drug design#Revolutionary approaches#transforming life#Technology Revolutionary